English Journal
- Mirimostim (macrophage colony-stimulating factor; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function.
- Hidaka T, Akada S, Teranishi A, Morikawa H, Sato S, Yoshida Y, Yajima A, Yaegashi N, Okamura K, Saito S.SourceDepartment of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Sugitani, Toyoma-shi, Toyama 930-0194, Japan. s30saito@ms.toyama-mpu.ac.jp
- Cancer science.Cancer Sci.2003 Sep;94(9):814-20.
- The purpose of this study was to clarify the effects of mirimostim (macrophage colony-stimulating factor; M-CSF) on immunological functions after chemotherapy. The percentage of natural killer (NK) cells in peripheral blood mononuclear cells (PBMCs), NK cell activity, T-helper cell 1/T-helper cell 2
- PMID 12967481
Japanese Journal
- Mirimostim (macrophage colony-stimulating factor ; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function
- Cancer science 94(9), 814-820, 2003-09-30
- NAID 10012438146
- 白血球減少症治療剤ミリモスチム
- ファルマシア 28(1), 60, 1992-01-01
- NAID 110003646753
Related Links
- Mirimostim is a medicine available in a number of countries worldwide. A list of US medications equivalent to Mirimostim is available on the Drugs.com website. ... Drugs.com provides accurate and independent information on more ...
- Mirimostim (macrophage colony-stimulating factor ; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function
Related Pictures
★リンクテーブル★
| リンク元 | 「ミリモスチム」 |
「ミリモスチム」
- 英
- mirimostim
- 商
- ロイコプロール
- 関
- その他の血液・体液用薬